Image of hexagons overlapping in different sizes

Regulatory Perspectives on the Accelerated Development of Bamlanivimab - a SARS-CoV-2 Neutralizing Antibody

Home / Papers and Presentations / Resource
Image with text 'CMC Strategy Forum Advancing Biopharmaceutical Development Latin America'
Speaker Presentation Dobbins JR, Eli Lilly and Company, 2021
Regulatory Perspectives on the Accelerated Development of Bamlanivimab - a SARS-CoV-2 Neutralizing Antibody

Related Files